Sort
326,823 grants matching “clinical trial”
Alzheimer's Disease Genetics Consortium
$3,980,408Gerard David Schellenberg · University Of Pennsylvania · U01 · FY2023 · AG
The A3 Study: Ante-Amyloid Prevention of Alzheimer's disease
$3,980,365Reisa A. Sperling · Brigham And Women'S Hospital · R01 · FY2021 · AG
ZZ-3K3A-301: A multicenter, randomized, placebo-controlled, double-blinded, Phase 3 study to evaluate the efficacy and safety of 3K3A-APC (RHAPSODY-2)
$3,980,070Patrick D Lyden · University Of Southern California · UG3 · FY2022 · NS
The A3 Study: Ante-Amyloid Prevention of Alzheimer's disease
$3,979,320Reisa A. Sperling · Brigham And Women'S Hospital · R01 · FY2023 · AG
NICHD Maternal-Fetal Medicine Units (MFMU) Network: Data CoordinatingCenter
$3,979,209Rebecca Gersnoviez Clifton · George Washington University · U24 · FY2025 · HD
Epidemiology of Diabetes Interventions and Complications^Data Coordinating Cente
$3,978,856George Washington University · N01 · FY2009 · DK
Support of NCI CCR Clinical Research and Bioinformatics
$3,978,851Jason Levine · Division Of Basic Sciences - Nci · ZIH · FY2020 · CA
Northern New England Clinical and Translational Research Network
$3,978,692Clifford J Rosen · Mainehealth · U54 · FY2019 · GM
SAMMPRIS (Stenting vs. Aggressive Medical Management for Preventing . . .
$3,978,265Marc Ivor Chimowitz · Medical University Of South Carolina · U01 · FY2008 · NS
SAMMPRIS (Stenting vs. Aggressive Medical Management for Preventing
$3,978,265Marc Ivor Chimowitz · Medical University Of South Carolina · U01 · FY2008 · NS
Cancer Center Support Grant
$3,978,214Timothy J Eberlein · Washington University · P30 · FY2007 · CA
Childhood Cancer Survivor Study
$3,978,213Leslie L Robison · St. Jude Children'S Research Hospital · U24 · FY2013 · CA
Center for Dental, Oral, and Craniofacial Tissue and Organ Regeneration (C-DOCTOR)
$3,978,064Jeffrey Charles Lotz · University Of California, San Francisco · U24 · FY2018 · DE
COMPREHENSIVE RESOURCES FOR HIV MICROBICIDE AND BIOMEDICAL PREVENTION
$3,976,501James Richardson · Advanced Bioscience Laboratories, Inc. · N01 · FY2013 · AI
SPIROMICS II: Biological underpinnings of COPD heterogeneity and progression
$3,976,480Prescott G Woodruff · University Of California, San Francisco · U01 · FY2020 · HL
Reproductive risk factors for Alzheimer's disease dementia and pathology
$3,974,970Walter A Rocca · Mayo Clinic Rochester · RF1 · FY2017 · AG
A novel therapeutic to ameliorate chronic pain and reduce opiate use
$3,973,837Boris Tabakoff · Lohocla Research Corporation · UH3 · FY2021 · DA
Adult Leukemia Research Center
$3,971,921Frederick R Appelbaum · Fred Hutchinson Cancer Research Center · P01 · FY2013 · CA
Helping to End Addiction Long-term (HEAL): New Chemical Structures for Pain, Addiction and Overdose Targets
$3,970,941Samuel Michael · National Center For Advancing Translational Sciences · ZIA · FY2023 · TR
Center for Dental, Oral, and Craniofacial Tissue and Organ Regeneration (C-DOCTOR)
$3,970,932Jeffrey Charles Lotz · University Of California, San Francisco · U24 · FY2019 · DE
Northeast Biodefense Center
$3,970,912Wadsworth Center · U54 · FY2003 · AI
Chronic Lymphocytic Leukemia Research Consortium
$3,970,539Thomas J. Kipps · University Of California, San Diego · P01 · FY2009 · CA
A Phase-2b, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-N-methyl-D-aspartate receptor (NMDAR) Encephalitis and Assess Markers of Disease
$3,970,523Stacey Lynn Clardy · University Of Utah · U01 · FY2022 · NS
Statistics Core
$3,968,903Sumithra Jay Mandrekar · Mayo Clinic Rochester · U10 · FY2019 · CA
Vulnerability of SARS- CoV-2 Infection in Lung Cancer Based on Serological Antibody Analyses
$3,968,419Fred R Hirsch · Icahn School Of Medicine At Mount Sinai · U54 · FY2020 · CA